U.S. flag

An official website of the United States government

GTR Home > Tests > OnkoSight Advanced Bladder Cancer Panel


Test order codeHelp: TP51

Test name


OnkoSight Advanced Bladder Cancer Panel

Purpose of the test


This is a clinical test intended for Help: Diagnosis, Drug Response, Predictive, Prognostic, Therapeutic management



Loading data ......

Click Indication tab for more information.

How to order


Order URL Help: https://www.genpathdiagnostics.com/

Specimen source

Paraffin block


Molecular Genetics
CSequence analysis of the entire coding region
Next-Generation (NGS)/Massively parallel sequencing (MPS)
  • Other

Summary of what is tested

Loading data ......

Click Methodology tab for more information.

Clinical utility


Not provided

Clinical validity


Not provided

Suggested reading

Clinical resources

Practice guidelines

  • NICE, 2024
    UK NICE Guideline NG101, Early and locally advanced breast cancer: diagnosis and management, 2024
  • NICE, 2023
    UK NICE Guideline NG12, Suspected cancer: recognition and referral, 2023
  • NCCN, 2023
    NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Breast Cancer, 2023
  • NCCN, 2023
    Breast Cancer, NCCN Guidelines Version 4.2022
  • NICE, 2018
    Tumour profiling tests to guide adjuvant chemotherapy decisions in early breast cancer (DG34)

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.